Статті в журналах з теми "Drug repurposing against COVID-19"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Drug repurposing against COVID-19".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Mohate, Pratiksha, and Madhav D. Zade. "REVIEW ON DRUG REPURPOSING DRUG USEFUL AGAINST COVID-19." International Journal of Engineering Applied Sciences and Technology 5, no. 2 (June 30, 2020): 449–55. http://dx.doi.org/10.33564/ijeast.2020.v05i02.074.
Повний текст джерелаRodrigues, Liliana, Renata Bento Cunha, Tatiana Vassilevskaia, Miguel Viveiros, and Celso Cunha. "Drug Repurposing for COVID-19: A Review and a Novel Strategy to Identify New Targets and Potential Drug Candidates." Molecules 27, no. 9 (April 23, 2022): 2723. http://dx.doi.org/10.3390/molecules27092723.
Повний текст джерелаKhataniar, Ankita, Upasana Pathak, Sanchaita Rajkhowa, and Anupam Nath Jha. "A Comprehensive Review of Drug Repurposing Strategies against Known Drug Targets of COVID-19." COVID 2, no. 2 (January 26, 2022): 148–67. http://dx.doi.org/10.3390/covid2020011.
Повний текст джерелаPuccetti, Matteo, Claudio Costantini, Maurizio Ricci, and Stefano Giovagnoli. "Tackling Immune Pathogenesis of COVID-19 through Molecular Pharmaceutics." Pharmaceutics 13, no. 4 (April 5, 2021): 494. http://dx.doi.org/10.3390/pharmaceutics13040494.
Повний текст джерелаWahedi, Hussain Mustatab, and Deeba Amraiz. "Repurposing of Antiviral Drugs for Covid-19 Therapy." Life and Science 1, supplement (December 23, 2020): 10. http://dx.doi.org/10.37185/lns.1.1.151.
Повний текст джерелаKumari, Priyanka, Bikram Pradhan, Maria Koromina, George P. Patrinos, and Kristel Van Steen. "Discovery of new drug indications for COVID-19: A drug repurposing approach." PLOS ONE 17, no. 5 (May 24, 2022): e0267095. http://dx.doi.org/10.1371/journal.pone.0267095.
Повний текст джерелаKumari, Kanchan, and Sandip K Mishra. "Artemisinin and its Derivatives as Repurposing Drug against COVID-19." Acta Scientific Cancer Biology 4, no. 7 (June 22, 2020): 21–23. http://dx.doi.org/10.31080/ascb.2020.04.0237.
Повний текст джерелаParvathaneni, Vineela, and Vivek Gupta. "Utilizing drug repurposing against COVID-19 – Efficacy, limitations, and challenges." Life Sciences 259 (October 2020): 118275. http://dx.doi.org/10.1016/j.lfs.2020.118275.
Повний текст джерелаCiliberto, Gennaro, and Luca Cardone. "Boosting the arsenal against COVID-19 through computational drug repurposing." Drug Discovery Today 25, no. 6 (June 2020): 946–48. http://dx.doi.org/10.1016/j.drudis.2020.04.005.
Повний текст джерелаKolitz, Sarah, Jason Kim, Jenny Zhang, Yoonjeong Cha, Sailaja Battula, Rebecca Kusko, Rajaraman Krishnan, Benjamin Zeskind, and Howard Kaufman. "477 Deep learning to drive COVID-19 rapid drug repurposing." Journal for ImmunoTherapy of Cancer 8, Suppl 3 (November 2020): A509. http://dx.doi.org/10.1136/jitc-2020-sitc2020.0477.
Повний текст джерелаSonkar, Charu, Pawan Kumar Doharey, Anuranjan Singh Rathore, Vishal Singh, Dharmendra Kashyap, Amaresh Kumar Sahoo, Nitish Mittal, Bechan Sharma, and Hem Chandra Jha. "Repurposing of gastric cancer drugs against COVID-19." Computers in Biology and Medicine 137 (October 2021): 104826. http://dx.doi.org/10.1016/j.compbiomed.2021.104826.
Повний текст джерелаPiplani, Sakshi, Puneet Singh, Nikolai Petrovsky, and David A. Winkler. "Identifying SARS-CoV-2 Drugs Binding to the Spike Fatty Acid Binding Pocket Using In Silico Docking and Molecular Dynamics." International Journal of Molecular Sciences 24, no. 4 (February 20, 2023): 4192. http://dx.doi.org/10.3390/ijms24044192.
Повний текст джерелаHossain, Md Shahadat, Ithmam Hami, Md Sad Salabi Sawrav, Md Fazley Rabbi, Otun Saha, Newaz Mohammed Bahadur, and Md Mizanur Rahaman. "Drug Repurposing for Prevention and Treatment of COVID-19: A Clinical Landscape." Discoveries 8, no. 4 (December 16, 2020): e121. http://dx.doi.org/10.15190/d.2020.18.
Повний текст джерелаHan, Namshik, Woochang Hwang, Konstantinos Tzelepis, Patrick Schmerer, Eliza Yankova, Méabh MacMahon, Winnie Lei, et al. "Identification of SARS-CoV-2–induced pathways reveals drug repurposing strategies." Science Advances 7, no. 27 (June 2021): eabh3032. http://dx.doi.org/10.1126/sciadv.abh3032.
Повний текст джерелаBen Moftah, Moayed, and Asma Eswayah. "Repurposing of Hydroxyurea Against COVID-19: A Promising Immunomodulatory Role." ASSAY and Drug Development Technologies 20, no. 1 (January 1, 2022): 55–62. http://dx.doi.org/10.1089/adt.2021.090.
Повний текст джерелаAherfi, Sarah, Bruno Pradines, Christian Devaux, Stéphane Honore, Philippe Colson, Bernard La Scola, and Didier Raoult. "Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV." Future Microbiology 16, no. 17 (November 2021): 1341–70. http://dx.doi.org/10.2217/fmb-2021-0019.
Повний текст джерелаKifle, Zemene Demelash, Akeberegn Gorems Ayele, and Engidaw Fentahun Enyew. "Drug Repurposing Approach, Potential Drugs, and Novel Drug Targets for COVID-19 Treatment." Journal of Environmental and Public Health 2021 (April 22, 2021): 1–11. http://dx.doi.org/10.1155/2021/6631721.
Повний текст джерелаSingh, Sanjeet, and Jayaram R. "A Review of Potential Antiviral Drugs and Vaccines to Treat COVID-19." Journal of Pure and Applied Microbiology 14, suppl 1 (May 28, 2020): 765–74. http://dx.doi.org/10.22207/jpam.14.spl1.14.
Повний текст джерелаNunes, Paulo, Pedro Henrique de Oliveira Santiago, Cecilia Carolina Pinheiro da Silva, and Javier Ellena. "Drug Repurposing of the Antiviral Drug Acyclovir: New Pharmaceutical Salts." Crystals 13, no. 5 (May 8, 2023): 782. http://dx.doi.org/10.3390/cryst13050782.
Повний текст джерелаAnand, Jigisha, Tanmay Ghildiyal, Aakanksha Madhwal, Rishabh Bhatt, Devvret Verma, and Nishant Rai. "Computational guided approach for drug repurposing against SARS-CoV-2." Future Virology 16, no. 3 (March 2021): 211–43. http://dx.doi.org/10.2217/fvl-2020-0403.
Повний текст джерелаLoganathan, Tamizhini, Srimathy Ramachandran, Prakash Shankaran, Devipriya Nagarajan, and Suma Mohan S. "Host transcriptome-guided drug repurposing for COVID-19 treatment: a meta-analysis based approach." PeerJ 8 (June 10, 2020): e9357. http://dx.doi.org/10.7717/peerj.9357.
Повний текст джерелаDe Vita, Simona, Maria Giovanna Chini, Gianluigi Lauro, and Giuseppe Bifulco. "Accelerating the repurposing of FDA-approved drugs against coronavirus disease-19 (COVID-19)." RSC Advances 10, no. 67 (2020): 40867–75. http://dx.doi.org/10.1039/d0ra09010g.
Повний текст джерелаLee, Jong hoon. "Treatment mechanism of immune triad from the repurposing drug against COVID-19." Translational Medicine of Aging 7 (2023): 33–45. http://dx.doi.org/10.1016/j.tma.2023.06.005.
Повний текст джерелаInstiaty, I. Gusti Agung Ayu Putu Sri Darmayani, Jefman Efendi Marzuki, Ferina Angelia, William, Angelina Siane, Lela Dwi Sary, et al. "Antiviral treatment of COVID-19: a clinical pharmacology narrative review." Medical Journal of Indonesia 29, no. 3 (July 18, 2020): 332–45. http://dx.doi.org/10.13181/mji.rev.204652.
Повний текст джерелаChowdhury, Kamrul Hasan, Md Riad Chowdhury, Shafi Mahmud, Abu Montakim Tareq, Nujhat Binte Hanif, Naureen Banu, A. S. M. Ali Reza, Talha Bin Emran, and Jesus Simal-Gandara. "Drug Repurposing Approach against Novel Coronavirus Disease (COVID-19) through Virtual Screening Targeting SARS-CoV-2 Main Protease." Biology 10, no. 1 (December 23, 2020): 2. http://dx.doi.org/10.3390/biology10010002.
Повний текст джерелаJang, Woo Dae, Sangeun Jeon, Seungtaek Kim, and Sang Yup Lee. "Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay." Proceedings of the National Academy of Sciences 118, no. 30 (July 7, 2021): e2024302118. http://dx.doi.org/10.1073/pnas.2024302118.
Повний текст джерелаTaibe, Noha Samir, Maimona A. Kord, Mohamed Ahmed Badawy, Iart Luca Shytaj, and Mahmoud M. Elhefnawi. "Progress, pitfalls, and path forward of drug repurposing for COVID-19 treatment." Therapeutic Advances in Respiratory Disease 16 (January 2022): 175346662211327. http://dx.doi.org/10.1177/17534666221132736.
Повний текст джерелаGupta, Rajesh Kumar, Girish R. Apte, Kiran Bharat Lokhande, Satyendra Mishra, and Jayanta K. Pal. "Carbohydrate-Binding Agents: Potential of Repurposing for COVID-19 Therapy." Current Protein & Peptide Science 21, no. 11 (December 31, 2020): 1085–96. http://dx.doi.org/10.2174/1389203721666200918153717.
Повний текст джерелаBR, Bharath, Hrishikesh Damle, Shiban Ganju, and Latha Damle. "In silico screening of known small molecules to bind ACE2 specific RBD on Spike glycoprotein of SARS-CoV-2 for repurposing against COVID-19." F1000Research 9 (July 1, 2020): 663. http://dx.doi.org/10.12688/f1000research.24143.1.
Повний текст джерелаMacRaild, Christopher A., Muzaffar-Ur-Rehman Mohammed, Faheem, Sankaranarayanan Murugesan, Ian K. Styles, Amanda L. Peterson, Carl M. J. Kirkpatrick, et al. "Systematic Down-Selection of Repurposed Drug Candidates for COVID-19." International Journal of Molecular Sciences 23, no. 19 (October 6, 2022): 11851. http://dx.doi.org/10.3390/ijms231911851.
Повний текст джерелаAlanazi, Khalid Mashay, Mohammad Abul Farah, and Yan-Yan Hor. "Multi-Targeted Approaches and Drug Repurposing Reveal Possible SARS-CoV-2 Inhibitors." Vaccines 10, no. 1 (December 26, 2021): 24. http://dx.doi.org/10.3390/vaccines10010024.
Повний текст джерелаNashte, Aayushka. "Exploring the Potential of Natural Compounds Against Pro-Inflammatory Cytokine Proteins Involved in Worsening COVID-19 and Against COVID-19 Proteins: An in Silico Approach." International Journal of Innovative Technology and Exploring Engineering 11, no. 9 (August 30, 2022): 74–98. http://dx.doi.org/10.35940/ijitee.g9221.0811922.
Повний текст джерелаGupta, Rajaneesh K., Enyinna L. Nwachuku, Benjamin E. Zusman, Ruchira M. Jha, and Ava M. Puccio. "Drug repurposing for COVID-19 based on an integrative meta-analysis of SARS-CoV-2 induced gene signature in human airway epithelium." PLOS ONE 16, no. 9 (September 28, 2021): e0257784. http://dx.doi.org/10.1371/journal.pone.0257784.
Повний текст джерелаHassanzadeganroudsari, Majid, Amir Hossein Ahmadi, Niloufar Rashidi, Md Kamal Hossain, Amanda Habib, and Vasso Apostolopoulos. "Computational Chemistry to Repurposing Drugs for the Control of COVID-19." Biologics 1, no. 2 (July 15, 2021): 111–28. http://dx.doi.org/10.3390/biologics1020007.
Повний текст джерелаMudatsir, Mudatsir, Amanda Yufika, Firzan Nainu, Andri Frediansyah, Dewi Megawati, Agung Pranata, Wilda Mahdani, Ichsan Ichsan, Kuldeep Dhama, and Harapan Harapan. "Antiviral Activity of Ivermectin Against SARS-CoV-2: An Old-Fashioned Dog with a New Trick—A Literature Review." Scientia Pharmaceutica 88, no. 3 (August 17, 2020): 36. http://dx.doi.org/10.3390/scipharm88030036.
Повний текст джерелаMorselli Gysi, Deisy, Ítalo do Valle, Marinka Zitnik, Asher Ameli, Xiao Gan, Onur Varol, Susan Dina Ghiassian, et al. "Network medicine framework for identifying drug-repurposing opportunities for COVID-19." Proceedings of the National Academy of Sciences 118, no. 19 (April 27, 2021): e2025581118. http://dx.doi.org/10.1073/pnas.2025581118.
Повний текст джерелаAsai, Ayumu, Masamitsu Konno, Miyuki Ozaki, Chihiro Otsuka, Andrea Vecchione, Takahiro Arai, Toru Kitagawa, et al. "COVID-19 Drug Discovery Using Intensive Approaches." International Journal of Molecular Sciences 21, no. 8 (April 18, 2020): 2839. http://dx.doi.org/10.3390/ijms21082839.
Повний текст джерелаGünther, Sebastian, Patrick Y. A. Reinke, Yaiza Fernández-García, Julia Lieske, Thomas J. Lane, Helen M. Ginn, Faisal H. M. Koua, et al. "X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease." Science 372, no. 6542 (April 2, 2021): 642–46. http://dx.doi.org/10.1126/science.abf7945.
Повний текст джерелаNarayanan, Anoop, Shay A. Toner, and Joyce Jose. "Structure-based inhibitor design and repurposing clinical drugs to target SARS-CoV-2 proteases." Biochemical Society Transactions 50, no. 1 (January 11, 2021): 151–65. http://dx.doi.org/10.1042/bst20211180.
Повний текст джерелаWang, Bing, Dmitri Svetlov, Dylan Bartikofsky, Christiane E. Wobus, and Irina Artsimovitch. "Going Retro, Going Viral: Experiences and Lessons in Drug Discovery from COVID-19." Molecules 27, no. 12 (June 14, 2022): 3815. http://dx.doi.org/10.3390/molecules27123815.
Повний текст джерелаCampbell, Courtney M., Avirup Guha, Tamanna Haque, Tomas G. Neilan, and Daniel Addison. "Repurposing Immunomodulatory Therapies against Coronavirus Disease 2019 (COVID-19) in the Era of Cardiac Vigilance: A Systematic Review." Journal of Clinical Medicine 9, no. 9 (September 11, 2020): 2935. http://dx.doi.org/10.3390/jcm9092935.
Повний текст джерелаGediz Erturk, Aliye, Arzu Sahin, Ebru Bati Ay, Emel Pelit, Emine Bagdatli, Irem Kulu, Melek Gul, et al. "A Multidisciplinary Approach to Coronavirus Disease (COVID-19)." Molecules 26, no. 12 (June 9, 2021): 3526. http://dx.doi.org/10.3390/molecules26123526.
Повний текст джерелаTrivedi, Jay, Mahesh Mohan, and Siddappa N. Byrareddy. "Drug Repurposing Approaches to Combating Viral Infections." Journal of Clinical Medicine 9, no. 11 (November 23, 2020): 3777. http://dx.doi.org/10.3390/jcm9113777.
Повний текст джерелаBaby, Krishnaprasad, Swastika Maity, Chetan H. Mehta, Akhil Suresh, Usha Y. Nayak, and Yogendra Nayak. "Targeting SARS-CoV-2 RNA-dependent RNA polymerase: An in silico drug repurposing for COVID-19." F1000Research 9 (September 23, 2020): 1166. http://dx.doi.org/10.12688/f1000research.26359.1.
Повний текст джерелаSourimant, Julien, Megha Aggarwal, and Richard K. Plemper. "Progress and pitfalls of a year of drug repurposing screens against COVID-19." Current Opinion in Virology 49 (August 2021): 183–93. http://dx.doi.org/10.1016/j.coviro.2021.06.004.
Повний текст джерелаRana, Prabha, and Vagisha Rawal. "Repurposing of drugs and leading vaccines work against COVID-19." Environment Conservation Journal 23, no. 1&2 (February 1, 2022): 39–48. http://dx.doi.org/10.36953/ecj.021904-2161.
Повний текст джерелаGhanbari, Reza, Ali Teimoori, Anahita Sadeghi, Ashraf Mohamadkhani, Sama Rezasoltani, Ebrahim Asadi, Abolghasem Jouyban, and Susan CJ Sumner. "Existing antiviral options against SARS-CoV-2 replication in COVID-19 patients." Future Microbiology 15, no. 18 (December 2020): 1747–58. http://dx.doi.org/10.2217/fmb-2020-0120.
Повний текст джерелаKiebish, Michael A., Punit Shah, Rangaprasad Sarangarajan, Vivek K. Vishnudas, Stephane Gesta, Poornima K. Tekumalla, Chas Bountra, et al. "Bayesian Model Infers Drug Repurposing Candidates for Treatment of COVID-19." Applied Sciences 11, no. 6 (March 10, 2021): 2466. http://dx.doi.org/10.3390/app11062466.
Повний текст джерелаRogosnitzky, Moshe, Esther Berkowitz, and Alejandro R. Jadad. "No Time to Waste: Real-World Repurposing of Generic Drugs as a Multifaceted Strategy Against COVID-19." JMIRx Med 1, no. 1 (September 30, 2020): e19583. http://dx.doi.org/10.2196/19583.
Повний текст джерелаFiscon, Giulia, Federica Conte, Lorenzo Farina, and Paola Paci. "SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19." PLOS Computational Biology 17, no. 2 (February 5, 2021): e1008686. http://dx.doi.org/10.1371/journal.pcbi.1008686.
Повний текст джерела